Congenital Cataract Surgery
ProcedureCongenital cataract surgery with IOL implantation
NCT Number: NCT01504607
Cataract surgery is known to cause loss of corneal endothelial cells. In adults, it is reported that anywhere between 2 to 15% loss of corneal endothelial cell density occurs following cataract surgery. However, no data is available regarding endothelial changes after cataract surgery with IOL implantation in pediatric eyes.
The aim of this study is to prospectively observe changes in endothelial cell density, coefficient of variation and hexagonality following cataract surgery with IOL implantation in pediatric eyes.
Looking for future studies?
Notify Me4 year–15 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Congenital cataract surgery with IOL implantation
Time frame: preoperatively to 3 months postoperatively
Change in corneal endothelial cell density, (CD), coefficient of variation (CV) and % of hexagonality (6A) were studied from preoperatively to 3 months postoperatively
Time frame: preoperatively to 3 months postoperatively
Change in central corneal thickness from preop to 3 months postop was studied
Iladevi Cataract and IOL Research Center
Other
Corneal Endothelial Morphologic Assessment in Pediatric Cataract Surgery With IOL Implantation: Comparison of Preoperative and Early Postoperative Specular Microscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07364370
Eye Diseases, Eye Neoplasms
Cairo, Egypt
View Trial DetailsNCT07051720
Behavior, Cataract
Ahaus, North Rhine-Westphalia, Germany
View Trial Details